C. Thomas Appleton, MD, PhD, FRCPC
Western University
London, ON, Canada
Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Matlock Jeffries, MD, FACP, FACR
Oklahoma Medical Research Foundation
Oklahoma City, OK, United States
Disclosure information not submitted.
Matlock Jeffries, MD, FACP, FACR
Oklahoma Medical Research Foundation
Oklahoma City, OK, United States
Disclosure information not submitted.
Are new/alternative therapies for knee osteoarthritis (OA) ready for prime time?
Speaker: C. Thomas Appleton, MD, PhD, FRCPC – Western University
Speaker: Lisa Mandl, MD;MPH – Hospital for Special Surgery